Physician profile
Timothy E Bowen
NPI 1083658132
$7,749.22
in general payments reported to CMS, 2019-2025
42 companies · $412 in 2025
The $412 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,785 · 2020: $1,002 · 2021: $1,822 · 2022: $1,003 · 2023: $834 · 2024: $891 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,117 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.82 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,006.86 | 2019-2025 | |
| Amgen INC. | $625.83 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $596.34 | 2019-2024 | Xarelto |
| Medtronic, INC. | $548.76 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Endologix LLC | $533.42 | 2019-2024 | Torus Stent Graft System, Endocross Device, Alto Abdominal Stent Graft System |
| Abbott Laboratories | $529.13 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Angio-Seal |
| Astrazeneca Pharmaceuticals Lp | $405.99 | 2019-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $341.06 | 2020-2025 | Lifevest |
| Medtronic Vascular, INC. | $270.70 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $255.38 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $248.39 | 2019-2023 | |
| Abiomed | $241.72 | 2019-2024 | Impella |
| Celonova Biosciences, INC. | $210.69 | 2019 | |
| Shockwave Medical, INC | $204.20 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Philips North America LLC | $161.35 | 2020-2024 | (Ck7) Extended Holter |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $142.61 | 2019-2025 | Cds - Mct/Cem Monitoring, Eluvia |
| Pfizer INC. | $140.33 | 2021-2024 | |
| Cvrx, INC. | $110.90 | 2022-2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.99 | 2021-2023 | Jardiance |
| Irhythm Technologies, INC. | $96.45 | 2022-2024 | Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $88.09 | 2019-2021 | |
| Cordis US Corp. | $77.79 | 2024-2025 | Mynx Venous Vcd, Mynx Control Venous |
| Gilead Sciences, INC. | $69.92 | 2019 | |
| Cardinal Health 200 LLC | $65.68 | 2019-2020 | |
| Astellas Pharma US INC | $62.88 | 2020-2021 | |
| Baxter Healthcare | $61.38 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Livanova USA, INC. | $56.27 | 2021 | |
| Cardiva Medical, INC. | $51.34 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amarin Pharma, INC. | $50.90 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $49.25 | 2022-2023 | |
| Novo Nordisk INC | $48.70 | 2023-2024 | Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $46.68 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Regeneron Healthcare Solutions, INC. | $41.97 | 2019 | |
| Esperion Therapeutics, INC. | $39.32 | 2020-2023 | Nexletol |
| Reflow Medical INC | $29.44 | 2025 | |
| Sirtex Medical INC | $23.82 | 2025 | Sir-Spheres Microspheres |
| Innovation Technologies INC | $23.13 | 2023 | Irrisept |
| Genzyme Corporation | $21.15 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.22 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $16.43 | 2024 | Arcalyst |
| Atricure, INC. | $15.76 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.